Key points from article :
Including immuno-oncology treatments, antibody delivery, Tau-aggregation inhibitors and mRNA therapies.
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Key points from article :
Including immuno-oncology treatments, antibody delivery, Tau-aggregation inhibitors and mRNA therapies.
Click on resource name for more details.
Company developing genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
Company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition
Company discovering and developing innovative therapeutic and diagnostic solutions targeting liver diseases
Biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies